Related Experiment Videos
Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes
Y Kitamura1, H Sasamura, T Maruyama
1Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Abstract:
Cushing's and Conn's syndromes are well recognised endocrine diseases, but the pathobiology of the tumors causing these disorders is unclear. In this study we examined AT1 and AT2 gene expression in adrenal adenomas of Cushing's and Conn's syndromes. AT1 and AT2 receptor mRNA, as well as alternatively spliced AT1 transcripts, were detected by RT-PCR using adjacent adrenal cortex tissue as controls. Whereas no consistent differences in AT1 mRNA were seen compared to control adrenal cortex, AT2 mRNA levels were significantly decreased in the adenomas of Cushing's and Conn's syndromes. No changes in alternative splicing of AT1 mRNA were observed in the adrenal tumors. The fact that no consistent changes were seen in AT1 mRNA or its splicing, whereas AT2 mRNA were reduced in both forms of hormone producing adrenal tumor suggests that the AT2 receptor, rather than the AT1 subtype, may be correlated with adrenal tumorigenesis.
Insights
Researchers investigated gene expression in adrenal tumors causing Cushing's and Conn's syndromes. AT2 receptor mRNA levels were significantly decreased in these tumors, suggesting a correlation between AT2 receptor and adrenal tumorigenesis.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Cushing's and Conn's syndromes are endocrine disorders caused by adrenal tumors.
- The specific molecular mechanisms driving adrenal tumor development remain unclear.
Purpose of the Study:
- To investigate the gene expression of angiotensin II receptors (AT1 and AT2) in adrenal adenomas associated with Cushing's and Conn's syndromes.
- To determine the role of AT1 and AT2 receptor subtypes in the pathobiology of these adrenal tumors.
Main Methods:
- Gene expression analysis using Reverse Transcription Polymerase Chain Reaction (RT-PCR).
- Quantification of AT1 and AT2 receptor mRNA levels in adrenal adenomas.
- Comparison of gene expression in tumor tissue versus adjacent normal adrenal cortex.
Main Results:
- AT2 receptor mRNA levels were significantly decreased in adrenal adenomas of both Cushing's and Conn's syndromes compared to normal adrenal cortex.
- No consistent differences in AT1 receptor mRNA levels were observed between tumors and normal tissue.
- Alternative splicing of AT1 mRNA showed no significant changes in the adrenal tumors.
Conclusions:
- The findings suggest that reduced AT2 receptor expression, not AT1 receptor expression or splicing, may be linked to the development of adrenal tumors causing Cushing's and Conn's syndromes.
- The AT2 receptor warrants further investigation as a potential factor in adrenal tumorigenesis.